Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes

Journal of the National Cancer Institute

Volumn 90, Issue 10, 1998, Pages 761-766

  Brunet, Jean Sébastien ^a   Ghadirian, Parviz ^b   Rebbeck, Timothy R ^c   Lerman, Caryn ^d   Garber, Judy E ^e   Tonin, Patricia N ^f,g   Abrahamson, John ^a   Foulkes, William D ^f,g   Daly, Mary ^h   Wagner Costalas, Josephine ^h   Godwin, Andrew ^h   Olopade, Olufunmilayo I ⁱ   Moslehi, Roxana ^j   Liede, Alexander ^a   Futreal, P Andrew ^k   Weber, Barbara L ^c   Lenoir, Gilbert M ^l   Lynch, Henry T ^m   Narod, Steven A ^a,n  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f Division of Medical Genetics   (Canada)

^g MCGILL UNIVERSITY   (Canada)

^h FOX CHASE CANCER CENTER   (United States)

ⁱ The University of Chicago Medicine

^j UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^k DUKE UNIVERSITY MEDICAL CENTER   (United States)

^l INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^m CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ WOMEN S COLLEGE HOSPITAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; RISK ASSESSMENT; SMOKING;

EID: 0032550761     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.10.761     Document Type: Article

References (28)

1. Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 1995;56:256-71.
2. Tonin P, Ghadirian P, Phelan C, Lenoir GM, Lynch HT, Letendre F, et al. A large multisite cancer family is linked to BRCA2. J Med Genet 1995;32:982-4.
3. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New Engl J Med 1997;336: 1401-8.
4. Narod SA, Goldgar D, Cannon-Albright L, Weber B, Moslehi R, Ives E, et al. Risk modifiers in carriers of BRCA1 mutations. Int J Cancer 1995;64:394-8.
5. Gayther SA, Mangion J, Russell P, Seal S, Barfoot R, Ponder BA, et al. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet 1997;15:103-5.
6. Baron JA, Newcomb PA, Longnecker MP, Mittendorf R, Storer BE, Clapp RW, et al. Cigarette smoking and breast cancer. Cancer Epidemiol Biomarkers Prev 1996;5: 399-403.
7. Baron JA, LaVecchia C, Levi F. The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol 1990;162:502-14.
8. Williams AR, Weiss NS, Ure CI, Ballard J, Daling JR. Effect of weight, smoking, and estrogen use on the risk of hip and forearm fractures in postmenopausal women. Obstet Gynecol 1982;60:695-9.
9. Lesko SM, Rosenberg L, Kaufman DW, Helmrich SP, Miller DR, Strom B, et al. Cigarette smoking and the risk of endometrial cancer. N Engl J Med 1985;313:593-6.
10. Calle EE, Miracle-McMahill HL, Thun MJ, Heath CW Jr. Cigarette smoking and risk of fatal breast cancer. Am J Epidemiol 1994;139: 1001-7.
11. Rimer BK, Orleans CT, Keintz MK, Cristinzio S, Fleisher L. The older smokers. Status, challenges and opportunities for intervention. Chest 1990;97:547-53.
12. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, et al. BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision making and outcomes. JAMA 1996; 275:1885-92.
13. Ambrosone CB, Freudenheim L, Graham S, Marshall JR, Vena JE, Brasure JR, et al. Cigarette smoking. N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 1996;276:1494-1501.
14. Zhang Y, Kiel DP, Kreger BE, Cupples LA, Ellison RC, Dorgan JF, et al. Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med 1997;336: 611-7.
15. MacMahon B, Trichopolous D, Cole P, Brown J. Cigarette smoking and urinary estrogens. N Engl J Med 1986;307:1062-8.
16. Thomas EJ, Edridge W, Weddell A, McGill A, McGarrigle HH. The impact of cigarette smoking on the plasma concentrations of gonadotrophins, ovarian steroids and androgens and upon the metabolism of oestrogens in the human female. Human Reprod 1993;8: 1187-93.
17. Berta L, Frairia R, Fortunati N, Fazzari A, Gaidano G. Smoking effects on the hormonal balance of fertile women. Horm Res 1992;37: 45-8.
18. Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL, Fishman J. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. New Engl J Med 1986;315: 1305-9.
19. Kabat GC, Chang CJ, Sparano JA, Sepkovie DW, Hu XP, Khalil A, et al. Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol Biomarkers Prev 1997;6:505-9.
20. Zheng W, Dunning L, Jin F, Holtzman J. Correspondence re: G.C. Kabat et al., Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol Biomark Prev 1997;6:505-9. Cancer Epidemiol Biomarkers Prev 1998;7:85-6.
21. Zheng W, Dunning L, Jin F, Holtzman J. Correspondence re: G.C. Kabat et al., Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol Biomark Prev 1997;6:505-9. Cancer Epidemiol Biomarkers Prev 1998;7:85-6.
22. Jensen J, Christiansen C, Rodbro P. Cigarette smoking, serum estrogens and bone loss during hormone-replacement therapy early after menopause. N Engl J Med 1985;313: 973-5.
23. Michels KB, Trichopolous D, Robins JM, Rosner BA, Manson JE, Hunter DJ, et al. Birthweight as a risk factor for breast cancer. Lancet 1996;348:1542-6.
24. Stoll BA. Birthweight as a risk factor for breast cancer. Lancet 1997;349:501.
25. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, et al. Serum insulin-like growth factor I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size and body mass index. J Clin Endocrinol Metab 1994;78: 744-52.
26. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosen T, Lindstedt G, Lundberg PA, et al. Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol 1994;41:351-7.
27. Peyrat JP, Bonneterre J, Hecquet B, Vennin P, Louchez MM, Fournier C, et al. Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. Eur J Cancer 1993;29: 492-7.
28. Hankinson S, Willett W, Colditz G, Hunter D, Michaud D, Deroo B, et al. Circulating insulin-like growth factor one level and risk of breast cancer. Lancet. In press.